Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) CEO Albert Cha Acquires 300,000 Shares of Stock

Key Points

  • CEO Albert Cha purchased 300,000 FLSC shares at an average price of $10.00, investing $3 million and increasing his ownership to 300,000 shares.
  • The insider transaction was disclosed in a filing with the SEC. FLSC shares opened at $10.49, near their 12-month high of $10.50.
  • Frazier Life Sciences Acquisition Corp. II is a SPAC seeking to merge with a life sciences company, potentially in biotechnology, pharmaceuticals, medical devices, diagnostics, or related healthcare technologies.

Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC - Get Free Report) CEO Albert Cha purchased 300,000 shares of the business's stock in a transaction on Thursday, October 15th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $3,000,000.00. Following the acquisition, the chief executive officer owned 300,000 shares in the company, valued at approximately $3,000,000. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Frazier Life Sciences Acquisition Corp. II Stock Performance

Shares of NASDAQ:FLSC opened at $10.49 on Friday. Frazier Life Sciences Acquisition Corp. II has a 12 month low of $10.18 and a 12 month high of $10.50.

About Frazier Life Sciences Acquisition Corp. II

(Get Free Report)

Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company, or SPAC, focused on identifying and combining with a business in the life sciences sector. The company does not operate a conventional commercial business and was formed to pursue a merger, acquisition, or similar business combination.

Its target opportunities may include companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, or other healthcare-related technologies. The company's objective is to provide a publicly traded platform for a private life sciences business through a business combination.

Frazier Life Sciences Acquisition Corp.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Frazier Life Sciences Acquisition Corp. II?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Frazier Life Sciences Acquisition Corp. II and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles